-
1
-
-
0027738064
-
The economic burden of depression in 1990
-
Greenberg, P. E.; Stiglin, L. E.; Finkelstein, S. N.; Berndt, E. R. The economic burden of depression in 1990. J. Clin. Psychiatry 1993, 54, 405-418.
-
(1993)
J. Clin. Psychiatry
, vol.54
, pp. 405-418
-
-
Greenberg, P.E.1
Stiglin, L.E.2
Finkelstein, S.N.3
Berndt, E.R.4
-
2
-
-
29544445541
-
Remission and recovery in depression treatment
-
Trivedi, M. H.; Kleiber, B.; Greer, T. L. Remission and recovery in depression treatment. Drug Dev. Res. 2005, 65, 335-343.
-
(2005)
Drug Dev. Res
, vol.65
, pp. 335-343
-
-
Trivedi, M.H.1
Kleiber, B.2
Greer, T.L.3
-
3
-
-
0019806188
-
Adverse effects of antidepressant drugs. Part 1: Monoamine oxidase inhibitors and tricyclics
-
Blackwell, B. Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics. Drugs 1981, 21, 201-219.
-
(1981)
Drugs
, vol.21
, pp. 201-219
-
-
Blackwell, B.1
-
4
-
-
52449122039
-
Recent approaches to novel antidepressant therapy
-
Evrard, D. A.; Harrison, B. L. Recent approaches to novel antidepressant therapy. Annu. Rep. Med. Chem. 1999, 34, 1-9.
-
(1999)
Annu. Rep. Med. Chem
, vol.34
, pp. 1-9
-
-
Evrard, D.A.1
Harrison, B.L.2
-
5
-
-
1642308531
-
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression
-
and references therein
-
Katz, M. M.; Tekell, J. L.; Bowden, C. L.; Brannan, S.; Houston, J. P.; Berman, N.; Frazer, A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 2004, 29, 566-579, and references therein.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 566-579
-
-
Katz, M.M.1
Tekell, J.L.2
Bowden, C.L.3
Brannan, S.4
Houston, J.P.5
Berman, N.6
Frazer, A.7
-
6
-
-
0029064827
-
Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo
-
Kreiss, D. S.; lucki, I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 1995, 274, 866-876.
-
(1995)
J. Pharmacol. Exp. Ther
, vol.274
, pp. 866-876
-
-
Kreiss, D.S.1
lucki, I.2
-
7
-
-
0031690668
-
New approaches to rapid onset antidepressants
-
(a) Briner, K.; Dodel, R. C. New approaches to rapid onset antidepressants. Curr. Pharm. Des. 1998, 4, 291-302.
-
(1998)
Curr. Pharm. Des
, vol.4
, pp. 291-302
-
-
Briner, K.1
Dodel, R.C.2
-
8
-
-
0008845504
-
1A receptor antagonists: Historical perspective and therapeutic targets
-
1A receptor antagonists: historical perspective and therapeutic targets. Serotonin 1997, 2, 299-309.
-
(1997)
Serotonin
, vol.2
, pp. 299-309
-
-
Schechter, L.E.1
Kelly, M.G.2
-
9
-
-
0029161526
-
Selective serotonin/noradrenaline reuptake site inhibitors (SNRIs)
-
Artigas, F. Selective serotonin/noradrenaline reuptake site inhibitors (SNRIs). CNS Drugs 1995, 4, 79-89.
-
(1995)
CNS Drugs
, vol.4
, pp. 79-89
-
-
Artigas, F.1
-
10
-
-
33846391983
-
Recent strategies for the development of new antidepressant drugs
-
Evrard, D. A. Recent strategies for the development of new antidepressant drugs. Annu. Rep. Med. Chem. 2006, 41, 23-38.
-
(2006)
Annu. Rep. Med. Chem
, vol.41
, pp. 23-38
-
-
Evrard, D.A.1
-
11
-
-
0027456795
-
Venlafaxine: A new dimension in antidepressant pharmacotherapy
-
Montgomery, S. A. Venlafaxine: a new dimension in antidepressant pharmacotherapy. J. Clin. Psychiatry 1993, 54, 119-126.
-
(1993)
J. Clin. Psychiatry
, vol.54
, pp. 119-126
-
-
Montgomery, S.A.1
-
12
-
-
21244493207
-
Venlafaxin XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo
-
Shelton, C.; Entsuah, R.; Padmanabhan, S. K.; Vinall, P. E. Venlafaxin XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo. Int. Clin. Psychopharmacol. 2005, 20, 233-238.
-
(2005)
Int. Clin. Psychopharmacol
, vol.20
, pp. 233-238
-
-
Shelton, C.1
Entsuah, R.2
Padmanabhan, S.K.3
Vinall, P.E.4
-
13
-
-
18844370877
-
The dual transporter inhibitor duloxetine: A review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression
-
Bymaster, F. P.; Lee, T. C.; Knadler, M. P.; Detke, M. J.; Iyengar, S. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Curr. Pharm. Des. 2005, 11, 1475-1493.
-
(2005)
Curr. Pharm. Des
, vol.11
, pp. 1475-1493
-
-
Bymaster, F.P.1
Lee, T.C.2
Knadler, M.P.3
Detke, M.J.4
Iyengar, S.5
-
14
-
-
1542404781
-
Effectiveness of pindolol plus serotonin uptake inhibitors in depression, a meta-analysis of early and late outcomes from randomized controlled trials
-
and references therein
-
Ballesteros, J.; Callado, L. F. Effectiveness of pindolol plus serotonin uptake inhibitors in depression, a meta-analysis of early and late outcomes from randomized controlled trials. J. Affective Disord. 2004, 79, 137-147, and references therein.
-
(2004)
J. Affective Disord
, vol.79
, pp. 137-147
-
-
Ballesteros, J.1
Callado, L.F.2
-
15
-
-
0030929916
-
1A receptor antagonists in the dorsal Raphe pathway: Role of somatodendritic autoreceptors
-
1A receptor antagonists in the dorsal Raphe pathway: role of somatodendritic autoreceptors. J. Neurochem. 1997, 68, 2593-2603.
-
(1997)
J. Neurochem
, vol.68
, pp. 2593-2603
-
-
Romero, L.1
Arigas, F.2
-
16
-
-
0031864268
-
The use of pindolol to potentiate antidepressant medication
-
Blier, P.; Bergeron, R. J. The use of pindolol to potentiate antidepressant medication. J. Clin. Psychiatry 1998, 59 (Suppl. 5), 16-23.
-
(1998)
J. Clin. Psychiatry
, vol.59
, Issue.SUPPL. 5
, pp. 16-23
-
-
Blier, P.1
Bergeron, R.J.2
-
17
-
-
0033135316
-
The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial
-
Berman, R. M.; Anand, A.; Cappiello, A.; Miller, H. L.; Xu, X. S.; Oren, D. A.; Charney, D. S. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol. Psychiatry 1999, 45, 1170-1177.
-
(1999)
Biol. Psychiatry
, vol.45
, pp. 1170-1177
-
-
Berman, R.M.1
Anand, A.2
Cappiello, A.3
Miller, H.L.4
Xu, X.S.5
Oren, D.A.6
Charney, D.S.7
-
18
-
-
0032936568
-
Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study
-
Gartside, S. E.; Clifford, E. M.; Cowen, P. J.; Sharp, T. Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Br. J. Pharmacol. 1999, 127, 145-152.
-
(1999)
Br. J. Pharmacol
, vol.127
, pp. 145-152
-
-
Gartside, S.E.1
Clifford, E.M.2
Cowen, P.J.3
Sharp, T.4
-
19
-
-
0036905983
-
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: An in-vivo microdialysis study
-
Beyer, C. E.; Boikess, S.; Luo, B.; Dawson, L. A. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J. Psychopharmacol 2002, 16, 297-304.
-
(2002)
J. Psychopharmacol
, vol.16
, pp. 297-304
-
-
Beyer, C.E.1
Boikess, S.2
Luo, B.3
Dawson, L.A.4
-
20
-
-
0035254214
-
1A serotonin receptors and serotonin transporter, as a new class of antidepressants
-
and references therein
-
1A serotonin receptors and serotonin transporter, as a new class of antidepressants. J. Med. Chem. 2001, 44, 418-428, and references therein.
-
(2001)
J. Med. Chem
, vol.44
, pp. 418-428
-
-
Martinez-Esparza, J.1
Oficialdegui, A.M.2
Perez-Silanes, S.3
Heras, B.4
Orus, L.5
Palop, J.A.6
Lasheras, B.7
Roca, J.8
Mourelle, M.9
Bosch, A.10
Del Castillo, J.C.11
Tordera, R.12
Del Rio, J.13
Monge, A.14
-
21
-
-
0035939309
-
Studies towards the next generation of antidepressants. Part 1. Indolylcyclohexylamines as potent serotonin reuptake inhibitors
-
(b) Meagher, K. L.; Mewshaw, R. E.; Evrard, D. A.; Zhou, P.; Smith, D. L.; Scerni, R.; Spangler, T.; Abulhawa, S.; Shi, X.; Schechter, L. E.; Andree, T. H. Studies towards the next generation of antidepressants. Part 1. Indolylcyclohexylamines as potent serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett. 2001, 11, 1885-1888.
-
(2001)
Bioorg. Med. Chem. Lett
, vol.11
, pp. 1885-1888
-
-
Meagher, K.L.1
Mewshaw, R.E.2
Evrard, D.A.3
Zhou, P.4
Smith, D.L.5
Scerni, R.6
Spangler, T.7
Abulhawa, S.8
Shi, X.9
Schechter, L.E.10
Andree, T.H.11
-
22
-
-
33644981174
-
1A receptor antagonism/SSRI activities. Part 5
-
and references therein
-
1A receptor antagonism/SSRI activities. Part 5. Bioorg. Med. Chem. Lett. 2006, 16, 2347-2351, and references therein.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 2347-2351
-
-
Takeuchi, K.1
Kohn, T.J.2
Honigschmidt, N.A.3
Rocco, V.P.4
Spinazze, P.G.5
Hemrick-Luecke, S.K.6
Thompson, L.K.7
Evans, D.C.8
Rasmussen, K.9
Koger, D.10
Lodge, D.11
Martin, L.J.12
Shaw, J.13
Threlkeld, P.G.14
Wong, D.T.15
-
23
-
-
20144389945
-
1A receptor
-
and references therein
-
1A receptor. Bioorg. Med. Chem. Lett. 2005, 15, 911-914, and references therein.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, pp. 911-914
-
-
Evrard, D.A.1
Zhou, P.2
Yi, S.3
Zhou, D.4
Smith, D.L.5
Sullivan, K.M.6
Hornby, G.A.7
Schechter, L.E.8
Andree, T.H.9
Mewshaw, R.E.10
-
24
-
-
0032403624
-
-
1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 3423-3428.
-
1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 3423-3428.
-
-
-
-
25
-
-
0028305246
-
1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure-activity relationship studies
-
1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure-activity relationship studies. J. Med. Chem. 1994, 37, 1779-1793.
-
(1994)
J. Med. Chem
, vol.37
, pp. 1779-1793
-
-
Podona, T.1
Guardiola-Lemaitre, B.2
Caignard, D.H.3
Adam, G.4
Pfeiffer, B.5
Renard, P.6
Guillaumet, G.7
-
26
-
-
0034721173
-
1A receptor
-
1A receptor. J. Med. Chem. 2000, 43, 2837-2850.
-
(2000)
J. Med. Chem
, vol.43
, pp. 2837-2850
-
-
Hammarberg, E.1
Nordvall, G.2
Leideborg, R.3
Nylof, M.4
Hanson, S.5
Johansson, L.6
Thorberg, S.-O.7
Tolf, B.-R.8
Jerning, E.9
Svantesson, G.T.10
Mohell, N.11
Ahlgren, C.12
Westlind-Danielsson, A.13
Csoregh, I.14
Johansson, R.15
-
27
-
-
0032725459
-
1A receptor antagonist
-
1A receptor antagonist. CNS Drug Rev. 1999, 5, 213-232.
-
(1999)
CNS Drug Rev
, vol.5
, pp. 213-232
-
-
Ross, S.B.1
Thorberg, S.-O.2
Jerning, E.3
Mohell, N.4
Stentors, C.5
Wallsten, C.6
Milchert, I.G.7
Ojteg, G.8
-
28
-
-
33746719300
-
1A receptor and serotonin transporter affinity
-
1A receptor and serotonin transporter affinity. J. Med. Chem. 2006, 49, 4785-4789.
-
(2006)
J. Med. Chem
, vol.49
, pp. 4785-4789
-
-
Hatzenbuhler, N.T.1
Evrard, D.A.2
Harrison, B.L.3
Huryn, D.4
Inghrim, J.5
Kraml, C.6
Mattes, J.F.7
Mewshaw, R.E.8
Zhou, D.9
Hornby, G.10
Lin, Q.11
Smith, D.L.12
Sullivan, K.M.13
Schechter, L.E.14
Beyer, C.E.15
Andree, T.H.16
-
29
-
-
0025912891
-
Methoxy and hydroxyl derivatives of 3,4-dihydro-3-(di-n-propyl-amino)-2H-1- benzopyrans: New synthesis and dopaminergic activity
-
Al Neirabeyeh, M.; Reynaud, D.; Podona, T.; Ou, L.; Perdicakis, C.; Coudert, G.; Guillaumet, G.; Pichat, L.; Gharib, A.; Sarda, N. Methoxy and hydroxyl derivatives of 3,4-dihydro-3-(di-n-propyl-amino)-2H-1- benzopyrans: new synthesis and dopaminergic activity. Eur. J. Med. Chem. 1991, 26, 497-504.
-
(1991)
Eur. J. Med. Chem
, vol.26
, pp. 497-504
-
-
Al Neirabeyeh, M.1
Reynaud, D.2
Podona, T.3
Ou, L.4
Perdicakis, C.5
Coudert, G.6
Guillaumet, G.7
Pichat, L.8
Gharib, A.9
Sarda, N.10
-
30
-
-
56249124838
-
-
Hammarberg, E. M, Johansson, L. G, Ross, S. B, Thorberg, S. O. 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl) carbamoylchroman. WO 93/07135, April 15, 1993
-
Hammarberg, E. M.; Johansson, L. G.; Ross, S. B.; Thorberg, S. O. 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl) carbamoylchroman. WO 93/07135, April 15, 1993.
-
-
-
-
31
-
-
56249146566
-
-
Evenden, J. L.; Hammarberg, E. M.; Hansson, H. S.; Hellberg, S. E.; Johansson, L. G.; Lundkvist, J. R. M.; Ross, S. B.; Sohn, D. D.; Thorberg, S. O. (R)-5-Carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro- 2H-1-benzopyrans. U.S. 5,616,610, April 1, 1997.
-
Evenden, J. L.; Hammarberg, E. M.; Hansson, H. S.; Hellberg, S. E.; Johansson, L. G.; Lundkvist, J. R. M.; Ross, S. B.; Sohn, D. D.; Thorberg, S. O. (R)-5-Carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro- 2H-1-benzopyrans. U.S. 5,616,610, April 1, 1997.
-
-
-
-
32
-
-
56249087475
-
-
Hanson, S.; Johansson, L.; Sohn, D. D. Process for the manufacture of 3-N,N-Dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5- carboxamide. U.S. 6,197,978 B1, March 6, 2001.
-
Hanson, S.; Johansson, L.; Sohn, D. D. Process for the manufacture of 3-N,N-Dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5- carboxamide. U.S. 6,197,978 B1, March 6, 2001.
-
-
-
-
33
-
-
56249098550
-
-
Hatzenbuhler, N. T.; Evrard, D. A.; Mewshaw, R. E.; Zhou, D.; Shah, U. S.; Inghrim, J. A.; Lenicek, S. E.; Baudy, R. B.; Butera, J. A.; Sabb, S. L.; Failli, A. A.; Ramamoorthy, P. S. A Preparation of 3-Aminochroman and 2-Aminotetralin Derivatives, Useful in the Treatment of Serotonin-Mediated Disorders. WO 2005/012291, February 10, 2005.
-
Hatzenbuhler, N. T.; Evrard, D. A.; Mewshaw, R. E.; Zhou, D.; Shah, U. S.; Inghrim, J. A.; Lenicek, S. E.; Baudy, R. B.; Butera, J. A.; Sabb, S. L.; Failli, A. A.; Ramamoorthy, P. S. A Preparation of 3-Aminochroman and 2-Aminotetralin Derivatives, Useful in the Treatment of Serotonin-Mediated Disorders. WO 2005/012291, February 10, 2005.
-
-
-
-
34
-
-
0001032345
-
tert-butyl N-acylimidodicarbonates as isolable acylating agents: Mild conversion of primary carboxamides to substituted amides
-
Davidsen, S. K.; May, P. D.; Summers, J. B. Di-tert-butyl N-acylimidodicarbonates as isolable acylating agents: mild conversion of primary carboxamides to substituted amides. J. Org. Chem. 1991, 56, 5482-5485.
-
(1991)
J. Org. Chem
, vol.56
, pp. 5482-5485
-
-
Davidsen, S.K.1
May, P.D.2
Summers, J.B.D.3
-
35
-
-
0036682044
-
Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity
-
Block, M. H.; Boyer, S.; Brailsford, W.; Brittain, D. R.; Carroll, D.; Chapman, S.; Clarke, D. S.; Donald, C. S.; Foote, K. M.; Godfrey, L.; Ladner, A.; Marsham, P. R.; Masters, D. J.; Mee, C. D.; O'Donovan, M. R.; Pease, J. E.; Pickup, A. G.; Rayner, J. W.; Roberts, A.; Schofield, P.; Suleman, A.; Turnbull, A. V. Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity. J. Med. Chem. 2002, 45, 3509-3523.
-
(2002)
J. Med. Chem
, vol.45
, pp. 3509-3523
-
-
Block, M.H.1
Boyer, S.2
Brailsford, W.3
Brittain, D.R.4
Carroll, D.5
Chapman, S.6
Clarke, D.S.7
Donald, C.S.8
Foote, K.M.9
Godfrey, L.10
Ladner, A.11
Marsham, P.R.12
Masters, D.J.13
Mee, C.D.14
O'Donovan, M.R.15
Pease, J.E.16
Pickup, A.G.17
Rayner, J.W.18
Roberts, A.19
Schofield, P.20
Suleman, A.21
Turnbull, A.V.22
more..
-
36
-
-
0036900930
-
Total synthesis of the cyclic peptide argyrin B
-
Ley, S. V.; Priour, A. Total synthesis of the cyclic peptide argyrin B. Eur. J. Org. Chem. 2002, 3995-4004.
-
(2002)
Eur. J. Org. Chem
, pp. 3995-4004
-
-
Ley, S.V.1
Priour, A.2
-
37
-
-
0000052926
-
Selective mono-alkylation of carbon nucleophiles with gramine
-
Somei, M.; Karasawa, Y.; Kaneko, C. Selective mono-alkylation of carbon nucleophiles with gramine. Heterocycles 1981, 16, 941-949.
-
(1981)
Heterocycles
, vol.16
, pp. 941-949
-
-
Somei, M.1
Karasawa, Y.2
Kaneko, C.3
-
40
-
-
0029154207
-
Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in chloriocarcinoma cells
-
Ramamoorthy, J. D.; Ramamoorthy, S.; Papapetropoulos, A.; Catravas, J. D.; Leibach, F. H.; Ganapathy, V. Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in chloriocarcinoma cells. J. Biol. Chem. 1995, 270, 17189-17195.
-
(1995)
J. Biol. Chem
, vol.270
, pp. 17189-17195
-
-
Ramamoorthy, J.D.1
Ramamoorthy, S.2
Papapetropoulos, A.3
Catravas, J.D.4
Leibach, F.H.5
Ganapathy, V.6
-
41
-
-
0021892571
-
3H]8-Hydroxy-2-(di-n-propylamino) tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain
-
3H]8-Hydroxy-2-(di-n-propylamino) tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 1985, 44, 1685-1696.
-
(1985)
J. Neurochem
, vol.44
, pp. 1685-1696
-
-
Hall, M.D.1
El Mestikawy, S.2
Emerit, M.B.3
Pichat, L.4
Hamon, M.5
Gozlan, H.6
-
42
-
-
0027313323
-
35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: Antagonist studies
-
35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmacol. 1993, 109, 1120-1127.
-
(1993)
Br. J. Pharmacol
, vol.109
, pp. 1120-1127
-
-
Larenzo, S.1
Birdsall, N.J.2
|